Literature DB >> 9242356

In vitro inhibition of CYP2B1 monooxygenase by beta-myrcene and other monoterpenoid compounds.

A C De-Oliveira1, L F Ribeiro-Pinto, J R Paumgartten.   

Abstract

beta-myrcene (MYR) is an acyclic monoterpene found in the essential oils of several useful plants such as lemongrass (Cymbopogon citratus), hop, bay, verbena and others. Recently it has been reported that MYR as well as lemongrass oil blocked the metabolic activation of some promutagens (e.g., cyclophosphamide and aflatoxin B1) in in vitro genotoxicity assays. The present study was performed to evaluate the inhibitory effects of MYR and some other monoterpenoid compounds on microsomal enzymes involved in the activation of genotoxic substances. The effects of MYR and other monoterpenes on the activity of pentoxyresorufin-O-depenthylase (PROD), a selective marker for CYP2B1, was determined in a pool of liver microsomes prepared from phenobarbital-treated rats. The effect of MYR on the activity of ethoxyresorufin-O-deethylase (EROD), a marker for CYP4501A1, was investigated in liver microsomes of untreated rats. Results revealed that MYR had almost no effect on EROD (IC50 > 50 microM), but produced a concentration-dependent inhibition of PROD activity (IC50 =0.14 microM). The analysis of alterations produced by MYR on PROD kinetic parameters (Lineweaver-Burk plot) suggested that inhibition is competitive (Ki = 0.14 microM). The inhibitory effects of seven other monoterpenes on PROD activity (pentoxyresorufin 5 microM) were also studied and the IC50 were as follows: (-)-alpha-pinene, 0.087 microM; (+)-alpha-pinene, 0.089 microM; d-limonene, 0.19 microM; alpha-terpinene, 0.76 microM; citral, 1.19 microM; citronellal, 1.56 microM, and (+/-) camphor, 7.89 microM. The potent inhibitory effects on CYP4502B1 suggest that MYR, and other monoterpenes, interfere with the metabolism of xenobiotics which are substrates for this isoenzyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242356     DOI: 10.1016/s0378-4274(97)00034-9

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  17 in total

Review 1.  Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.

Authors:  Nicolette Perry; Elaine Perry
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Acaricidal and quantitative structure activity relationship of monoterpenes against the two-spotted spider mite, Tetranychus urticae.

Authors:  Mohamed E I Badawy; Sailan A A El-Arami; Samir A M Abdelgaleil
Journal:  Exp Appl Acarol       Date:  2010-04-30       Impact factor: 2.132

Review 3.  Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

Authors:  Ethan B Russo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Identification and sequencing of beta-myrcene catabolism genes from Pseudomonas sp. strain M1.

Authors:  S Iurescia; A M Marconi; D Tofani; A Gambacorta; A Paternò; C Devirgiliis; M J van der Werf; E Zennaro
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

5.  Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.

Authors:  Ana Cecilia A X De-Oliveira; Renato S Carvalho; Flavio H M Paixão; Hellen S Tavares; Luciana S Gueiros; Carolina M Siqueira; Francisco J R Paumgartten
Journal:  Malar J       Date:  2010-03-22       Impact factor: 2.979

6.  Functional characterization of cytochromes P450 2B from the desert woodrat Neotoma lepida.

Authors:  P Ross Wilderman; Hyun-Hee Jang; Jael R Malenke; Mariam Salib; Elisabeth Angermeier; Sonia Lamime; M Denise Dearing; James R Halpert
Journal:  Toxicol Appl Pharmacol       Date:  2013-12-19       Impact factor: 4.219

7.  Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.

Authors:  Ana C A X De-Oliveira; Kátia S Poça; Paulo R R Totino; Francisco J R Paumgartten
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

8.  Genotoxic and Antigenotoxic Assessment of Chios Mastic Oil by the In Vitro Micronucleus Test on Human Lymphocytes and the In Vivo Wing Somatic Test on Drosophila.

Authors:  Dimitris Vlastos; Elena Drosopoulou; Ioanna Efthimiou; Maximos Gavriilidis; Dimitra Panagaki; Krystalenia Mpatziou; Paraskevi Kalamara; Despoina Mademtzoglou; Penelope Mavragani-Tsipidou
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

9.  Modulation of CYP1A1 and CYP1A2 hepatic enzymes after oral administration of Chios mastic gum to male Wistar rats.

Authors:  Efrosini S Katsanou; Katerina Kyriakopoulou; Christina Emmanouil; Nikolas Fokialakis; Alexios-Leandros Skaltsounis; Kyriaki Machera
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

10.  Isolation of Bioactive Compounds That Relate to the Anti-Platelet Activity of Cymbopogon ambiguus.

Authors:  I Darren Grice; Kelly L Rogers; Lyn R Griffiths
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.